↓ Skip to main content

Dove Medical Press

Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report

Overview of attention for article published in OncoTargets and therapy, June 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
4 X users
reddit
1 Redditor

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
15 Mendeley
Title
Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report
Published in
OncoTargets and therapy, June 2021
DOI 10.2147/ott.s312889
Pubmed ID
Authors

Brice Leyrat, Xavier Durando, Hugo Veyssiere, Maureen Bernadach

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 20%
Student > Master 2 13%
Unspecified 1 7%
Student > Bachelor 1 7%
Other 1 7%
Other 2 13%
Unknown 5 33%
Readers by discipline Count As %
Medicine and Dentistry 6 40%
Biochemistry, Genetics and Molecular Biology 2 13%
Unspecified 1 7%
Unknown 6 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2021.
All research outputs
#15,496,121
of 25,872,466 outputs
Outputs from OncoTargets and therapy
#792
of 3,017 outputs
Outputs of similar age
#226,388
of 463,253 outputs
Outputs of similar age from OncoTargets and therapy
#14
of 87 outputs
Altmetric has tracked 25,872,466 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,017 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 463,253 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.